Intravenous cefiderocol for neurosurgical meningitis from an extensively drug-resistant New-Delhi metallo-β-lactamase-producing Pseudomonas aeruginosa strain

• Daniel R. Stevenson,
• Benny P. Cherian,
• Martina Kinzig,
• Fritz Sörgel,
• David W Wareham

Affiliations

Daniel R. Stevenson

Microbiology and Infectious Diseases, Royal London Hospital, Barts Health NHS Trust, London UK; Corresponding author. Mailing address: Division of Infection, Royal London Hospital, Barts Health NHS Trust, London UK, E1 1FR

Benny P. Cherian

Microbiology and Infectious Diseases, Royal London Hospital, Barts Health NHS Trust, London UK

Martina Kinzig

Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany

Fritz Sörgel

Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany

David W Wareham

Antimicrobial Research Group, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK